Abstract:The adenovirus vector vaccines induce humoral and cellular immune responses and have been used to develop vaccines for effective prevention of life-threating viruses, such as Ebola and Coronaviruses. High demand of vaccines worldwide requires optimization of the production process. Perfusion process increases cell concentration and volumetric productivity, so that it becomes the commonly used strategy in vaccine production In this study, we optimized and developed a perfusion process for the adenovirus-based zoster vaccine production efficiently. We first tested different perfusion strategies in shake flasks, showing semi-continuous strategies for optimal HEK 293 cell growth. We then evaluated three empirical key process parameters (cell concentration at the time of infection (VCC), multiplicity of infection (MOI), virus production pH) by the design of experiment (DoE) method, from which the robust setpoint (VCC 1.04 × 10<sup>7</sup> cells/mL, MOI 9, and virus production pH 7.17) was confirmed in both shake flask and 2 L benchtop bioreactor. In the bioreactor, we compared the performances of two perfusion systems, the commercially-available XCell ATF® system and a novel peristaltic pump-driven alternating tangential flow perfusion system (PATFP system) that we developed. During cell cultivation stage, both perfusion systems have comparable performances regarding viable cell concentration and cell viability. At 2 dpi, the PATFP system resulted in an adenovirus titer of 2.1 × 10<sup>10</sup> IFU/mL and cell-specific virus yield of 2,062 IFU/cell, reaching 75% and 77% of values for XCell ATF® system. This study demonstrates the perfusion process to be superior strategy for adenovirus-based vaccine production compared to the batch-mode strategy (1,467 IFU/cell). Furthermore, our PATFP system shows potential to be comparable to the XCell ATF® system, and it would become an alternative perfusion strategy for the vaccine production.

Optimization of process parameters for specific pathogen-free chicken embryonic fibroblast cultivation for yellow fever vaccine production

Enhanced production of yellow fever virus through tailored culture media optimization

Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine

A Bioreactor-Based Yellow Fever Virus-like Particle Production Process with Integrated Process Analytical Technology Based on Transient Transfection

Cultivation, Identification, and Parameter Optimization of Chicken Embryo Fibroblast (CEF) in Primary Culture

The Avian EB66(R) Cell Line, Application to Vaccines, and Therapeutic Protein Production

YF17D‐based vaccines – standing on the shoulders of a giant

Process optimization for the rapid production of Enterovirus 71

Highly Efficient Production of an Influenza H9N2 Vaccine Using MDCK Suspension Cells

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge

Insect cell production of chimeric virus-like particles based on human immunodeficiency virus GAG proteins and yellow fever virus envelope protein

Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains

Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism

Advancing molecular modeling and reverse vaccinology in broad-spectrum yellow fever virus vaccine development

Construction of a Peacock Immortalized Fibroblast Cell Line for Avian Virus Production.

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models

Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine

Medium optimization based on comparative metabolomic analysis of chicken embryo fibroblast DF-1 cells

The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process

Coupling Metabolomics Analysis and DOE Optimization Strategy Towards Enhanced IBDV Production by Chicken Embryo Fibroblast DF-1 Cells

Generation and Application of a Luciferase Reporter Virus Based on Yellow Fever Virus 17D